Home › Glioma › Florida › Miami
Glioma clinical trials in Miami, FL
15 studies for Glioma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RecruitingPhase 1/2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Miami Cancer Institute, Miami
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- Nicklaus Children's Hospital, Miami
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- University of Miami, Miami
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- University of Miami Hospital and Clinics, Miami
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- University of Miami Health, Miami
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Nicklaus Children's Hospital, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- University of Miami Hospital and Clinics, Miami
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
RecruitingPhase 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
STARLITE for Unresectable High-Grade Gliomas
RecruitingPhase 1
- University of Miami, Miami
PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
Recruiting
- Miami Cancer Institute at Baptist Health, Inc., Miami
DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
RecruitingPhase 2
- University of Miami Hospital, Miami
Non-invasive Glioma Characterization Through Molecular Imaging
Recruiting
- University of Miami, Miami
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
RecruitingPhase 1/2
- University of Miami, Miami
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
RecruitingPhase 1/2
- University of Miami Hospital, Miami
Glioma trials in other cities
- New York City, NY25 studies
- Houston, TX23 studies
- Boston, MA20 studies
- Washington, DC19 studies
- Philadelphia, PA16 studies
- Columbus, OH15 studies
- San Francisco, CA14 studies
- Chicago, IL13 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Los Angeles, CA10 studies
- St. Louis, MO10 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer27 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Overweight23 studies
- Multiple Myeloma21 studies
- Ulcerative Colitis21 studies
- Alzheimer's Disease20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.